Related Experiment Video

Updated: Mar 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K

Do Naranjo Criteria Still Apply to Ipilimumab-induced Uveitis?

Yan Guex-Crosier1

  • 1Jules Gonin Eye Hospital, FAA, University of Lausanne, Switzerland.

Klinische Monatsblatter Fur Augenheilkunde
|April 27, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

2.0K

Related Experiment Videos

Last Updated: Mar 22, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.3K
Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.3K
Iris Fixation via External Pentagram Suturing
05:22

Iris Fixation via External Pentagram Suturing

Published on: May 5, 2022

2.0K

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K

Articles linked to this work by shared authors, journal, and citation graph.

Persistent placoid maculopathy: long term outcomes and prognostic factors.

Retina (Philadelphia, Pa.)·2026

Retinal vascular occlusions during COVID-19: an epidemiological survey.

Frontiers in ophthalmology·2026

UveAI: clinic-ready scoring of retinal inflammation in uveitis on widefield fluorescein angiography using AI.

Scientific reports·2026

Are the SUN Criteria Sufficient for Tubercular Uveitis? Findings From a Multinational Registry Study.

Investigative ophthalmology & visual science·2026

A case of paracentral acute middle maculopathy and retinal vein occlusion: idiopathic occlusive retinal vasculitis or incomplete Behçet's disease?

BMC ophthalmology·2025

Programme for ocular inflammation & infection translational research (PROTON) registry: Cross-sectional analysis of baseline patient characteristics.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)·2025

[Type 2 Macular Telangiectasia: Pathogenesis-The Interplay Between Neurodegeneration and Metabolic Changes].

Klinische Monatsblatter fur Augenheilkunde·2026

Macular Telangiectasia Type 2: Current and Emerging Diagnostic Imaging Modalities.

Klinische Monatsblatter fur Augenheilkunde·2026

Straylight-Based Evaluation of Glare in Two Presbyopia-Correcting Intraocular Lenses.

Klinische Monatsblatter fur Augenheilkunde·2026

An Eight-Year Review of Paediatric Ophthalmic Surgical Services at a Tertiary Eye Centre in Malawi.

Klinische Monatsblatter fur Augenheilkunde·2026

The Pathological Work-Life Model of the Chronic Glaucoma Patient: Risk Factors and Therapeutic Tips.

Klinische Monatsblatter fur Augenheilkunde·2026

Surgical Management of Malignant Eyelid Tumors: A Retrospective Analysis over 10 Years of Surgical Treatment in 1443 Consecutive Cases.

Klinische Monatsblatter fur Augenheilkunde·2026

[Sarcoidosis from an immunological perspective - experience-based diagnosis and treatment with targeted therapies].

Therapeutische Umschau. Revue therapeutique·2026

[Immune-related adverse events of immune checkpoint inhibitors].

Therapeutische Umschau. Revue therapeutique·2026

Therapeutic drug monitoring of adalimumab for dose optimization during maintenance therapy in patients with ulcerative colitis: real-world data.

Folia medica·2026

Correction: A robust and scalable immunoadsorbent platform based on the high-affinity M03-IgG antibody for targeted IL-6 Removal in cytokine storm.

Frontiers in immunology·2026

Expanded dendritic cells loaded with placental gp96 to generate antigen-specific T cells for anti-tumor immunity: an in vitro study.

Central-European journal of immunology·2026

Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.

MedComm·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us